Abstract
Polymer-based nanomedicines have been engineered to ratiometrically deliver three different drugs to tumors, thereby bridging in vitro–in vivo correlation and producing synergistic therapeutic efficacy in multiple myeloma mouse models.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have